vs
InterDigital, Inc.（IDCC）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
InterDigital, Inc.的季度营收约是REPLIGEN CORP的1.0倍（$205.4M vs $197.9M），InterDigital, Inc.净利率更高（36.7% vs 6.7%，领先29.9%），REPLIGEN CORP同比增速更快（13.6% vs -2.4%），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs -4.1%）
InterDigital, Inc.是一家美国科技研发企业，成立于1972年，于纳斯达克挂牌上市，为标普600指数成分股，面向全球市场为移动设备、通信网络及相关服务领域提供无线与视频技术解决方案，在相关技术研发领域拥有深厚积累。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
IDCC vs RGEN — 直观对比
营收规模更大
IDCC
是对方的1.0倍
$197.9M
营收增速更快
RGEN
高出16.1%
-2.4%
净利率更高
IDCC
高出29.9%
6.7%
两年增速更快
RGEN
近两年复合增速
-4.1%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $205.4M | $197.9M |
| 净利润 | $75.3M | $13.3M |
| 毛利率 | — | 52.5% |
| 营业利润率 | 40.0% | 9.0% |
| 净利率 | 36.7% | 6.7% |
| 营收同比 | -2.4% | 13.6% |
| 净利润同比 | -34.8% | 143.9% |
| 每股收益（稀释后） | $2.14 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IDCCRGEN
| Q1 26 | $205.4M | — | ||
| Q4 25 | $158.2M | $197.9M | ||
| Q3 25 | $164.7M | $188.8M | ||
| Q2 25 | $300.6M | $182.4M | ||
| Q1 25 | $210.5M | $169.2M | ||
| Q4 24 | $252.8M | $174.1M | ||
| Q3 24 | $128.7M | $154.9M | ||
| Q2 24 | $223.5M | $154.1M |
净利润IDCCRGEN
| Q1 26 | $75.3M | — | ||
| Q4 25 | $43.0M | $13.3M | ||
| Q3 25 | $67.5M | $14.9M | ||
| Q2 25 | $180.6M | $14.9M | ||
| Q1 25 | $115.6M | $5.8M | ||
| Q4 24 | $133.1M | $-30.3M | ||
| Q3 24 | $34.2M | $-654.0K | ||
| Q2 24 | $109.7M | $3.3M |
毛利率IDCCRGEN
| Q1 26 | — | — | ||
| Q4 25 | — | 52.5% | ||
| Q3 25 | — | 53.2% | ||
| Q2 25 | — | 50.0% | ||
| Q1 25 | — | 53.6% | ||
| Q4 24 | — | 26.1% | ||
| Q3 24 | — | 50.0% | ||
| Q2 24 | — | 49.8% |
营业利润率IDCCRGEN
| Q1 26 | 40.0% | — | ||
| Q4 25 | 30.2% | 9.0% | ||
| Q3 25 | 46.0% | 8.9% | ||
| Q2 25 | 68.3% | 7.6% | ||
| Q1 25 | 62.6% | 3.9% | ||
| Q4 24 | 64.3% | -17.7% | ||
| Q3 24 | 30.6% | -5.1% | ||
| Q2 24 | 59.9% | 1.0% |
净利率IDCCRGEN
| Q1 26 | 36.7% | — | ||
| Q4 25 | 27.2% | 6.7% | ||
| Q3 25 | 41.0% | 7.9% | ||
| Q2 25 | 60.1% | 8.2% | ||
| Q1 25 | 54.9% | 3.4% | ||
| Q4 24 | 52.7% | -17.4% | ||
| Q3 24 | 26.6% | -0.4% | ||
| Q2 24 | 49.1% | 2.2% |
每股收益（稀释后）IDCCRGEN
| Q1 26 | $2.14 | — | ||
| Q4 25 | $1.07 | $0.24 | ||
| Q3 25 | $1.93 | $0.26 | ||
| Q2 25 | $5.35 | $0.26 | ||
| Q1 25 | $3.45 | $0.10 | ||
| Q4 24 | $4.12 | $-0.55 | ||
| Q3 24 | $1.14 | $-0.01 | ||
| Q2 24 | $3.93 | $0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $767.6M |
| 总债务越低越好 | $377.8M | $542.2M |
| 股东权益账面价值 | $1.1B | $2.1B |
| 总资产 | $2.1B | $2.9B |
| 负债/权益比越低杠杆越低 | 0.34× | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资IDCCRGEN
| Q1 26 | — | — | ||
| Q4 25 | $1.2B | $767.6M | ||
| Q3 25 | $1.3B | $748.7M | ||
| Q2 25 | $937.0M | $708.9M | ||
| Q1 25 | $883.3M | $697.2M | ||
| Q4 24 | $958.2M | $757.4M | ||
| Q3 24 | $813.2M | $784.0M | ||
| Q2 24 | $760.3M | $809.1M |
总债务IDCCRGEN
| Q1 26 | $377.8M | — | ||
| Q4 25 | $16.3M | $542.2M | ||
| Q3 25 | $17.1M | $537.9M | ||
| Q2 25 | $16.6M | — | ||
| Q1 25 | $16.0M | — | ||
| Q4 24 | $15.4M | $525.6M | ||
| Q3 24 | $18.3M | — | ||
| Q2 24 | $17.7M | — |
股东权益IDCCRGEN
| Q1 26 | $1.1B | — | ||
| Q4 25 | $1.1B | $2.1B | ||
| Q3 25 | $1.1B | $2.1B | ||
| Q2 25 | $1.1B | $2.1B | ||
| Q1 25 | $936.9M | $2.0B | ||
| Q4 24 | $857.2M | $2.0B | ||
| Q3 24 | $722.5M | $2.0B | ||
| Q2 24 | $696.8M | $2.0B |
总资产IDCCRGEN
| Q1 26 | $2.1B | — | ||
| Q4 25 | $2.1B | $2.9B | ||
| Q3 25 | $2.1B | $2.9B | ||
| Q2 25 | $2.0B | $2.9B | ||
| Q1 25 | $1.9B | $2.9B | ||
| Q4 24 | $1.8B | $2.8B | ||
| Q3 24 | $1.7B | $2.8B | ||
| Q2 24 | $1.6B | $2.9B |
负债/权益比IDCCRGEN
| Q1 26 | 0.34× | — | ||
| Q4 25 | 0.01× | 0.26× | ||
| Q3 25 | 0.02× | 0.26× | ||
| Q2 25 | 0.02× | — | ||
| Q1 25 | 0.02× | — | ||
| Q4 24 | 0.02× | 0.27× | ||
| Q3 24 | 0.03× | — | ||
| Q2 24 | 0.03× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $25.7M |
| 自由现金流经营现金流 - 资本支出 | — | $17.6M |
| 自由现金流率自由现金流/营收 | — | 8.9% |
| 资本支出强度资本支出/营收 | — | 4.1% |
| 现金转化率经营现金流/净利润 | — | 1.93× |
| 过去12个月自由现金流最近4个季度 | — | $93.9M |
8季度趋势，按日历期对齐
经营现金流IDCCRGEN
| Q1 26 | — | — | ||
| Q4 25 | $544.5M | $25.7M | ||
| Q3 25 | $395.9M | $48.1M | ||
| Q2 25 | $105.1M | $28.6M | ||
| Q1 25 | $-20.0M | $15.0M | ||
| Q4 24 | $271.5M | $39.2M | ||
| Q3 24 | $77.6M | $49.3M | ||
| Q2 24 | $-48.9M | $42.2M |
自由现金流IDCCRGEN
| Q1 26 | — | — | ||
| Q4 25 | $528.6M | $17.6M | ||
| Q3 25 | $395.3M | $43.4M | ||
| Q2 25 | $104.5M | $21.5M | ||
| Q1 25 | $-34.5M | $11.4M | ||
| Q4 24 | $265.7M | $33.6M | ||
| Q3 24 | $76.7M | $42.3M | ||
| Q2 24 | $-49.5M | $37.4M |
自由现金流率IDCCRGEN
| Q1 26 | — | — | ||
| Q4 25 | 334.0% | 8.9% | ||
| Q3 25 | 240.1% | 23.0% | ||
| Q2 25 | 34.8% | 11.8% | ||
| Q1 25 | -16.4% | 6.8% | ||
| Q4 24 | 105.1% | 19.3% | ||
| Q3 24 | 59.6% | 27.3% | ||
| Q2 24 | -22.1% | 24.3% |
资本支出强度IDCCRGEN
| Q1 26 | — | — | ||
| Q4 25 | 10.0% | 4.1% | ||
| Q3 25 | 0.4% | 2.5% | ||
| Q2 25 | 0.2% | 3.9% | ||
| Q1 25 | 6.9% | 2.1% | ||
| Q4 24 | 2.3% | 3.2% | ||
| Q3 24 | 0.7% | 4.5% | ||
| Q2 24 | 0.3% | 3.1% |
现金转化率IDCCRGEN
| Q1 26 | — | — | ||
| Q4 25 | 12.67× | 1.93× | ||
| Q3 25 | 5.87× | 3.23× | ||
| Q2 25 | 0.58× | 1.92× | ||
| Q1 25 | -0.17× | 2.57× | ||
| Q4 24 | 2.04× | — | ||
| Q3 24 | 2.27× | — | ||
| Q2 24 | -0.45× | 12.70× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
